Why the study?
As cancer survival improves, the risk of cancer treatment-induced cardiovascular disease increases, necessitating dedicated multidisciplinary cardio-oncology expertise and management.
Different cancer treatments carry specific cardiovascular toxicity profiles, highlighting the critical need for multidisciplinary cardio-oncology clinics to manage risks such as heart failure, myocarditis, and coronary disease.
No takes yet. Share an insight, caveat, or question.
Kemp et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: